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Abstract
Lymphoepithelioma-like hepatocellular carcinoma (LEL-
HCC) is a rare form of undifferentiated carcinoma 
of the liver characterized by the presence of an 
abundant lymphoid infiltrate. Here, a case of LEL-HCC 
is described. An 81-year-old woman with a chronic 
hepatitis C infection was referred to the general 
surgery department of our hospital in August 2013 
with a diagnosis of HCC. A past ultrasound examination 
had revealed a 60 mm-diameter nodular lesion in the 
third segment of the liver. After a needle biopsy, the 
lesion was diagnosed as HCC. The patient underwent 
surgery with a liver segmentectomy. Two additional 
nodes on the gastric wall were detected during the 
surgical operation. The histology of the removed 
specimen showed a poorly differentiated HCC with 
significant lymphoid stroma. Immunohistochemical 
studies revealed that the epithelial component was 
reactive for CK CAM5.2, CK8, CK18, CEA (polyclonal) 
and was focally positive for hepar-1 and that the 
lymphoid infiltrate was positive for CD3, CD4 and CD8. 
The tumor cells were negative for Epstein-Barr virus. 
The gastric nodes were ultimately determined to be 
two small gastrointestinal stromal tumors (GISTs). 
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The synchronous occurrence of HCC and GIST is 
another very uncommon finding rarely described in 
the literature. Here, we report the clinicopathological 
features of our case, along with a review of the few 
cases present in the literature.
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Core tip: Here a case of Lymphoepithelioma-like 
hepatocellular carcinoma (HCC) described in a 81-year-
old woman with a chronic hepatitis C infection. An 
ultrasound examination revealed a nodular lesion in 
the third segment of the liver, diagnosed as HCC after 
a needle biopsy. The patient underwent surgery with 
a liver segmentectomy. Histology of the removed 
specimen showed a poorly differentiated HCC with 
a significant lymphoid stroma. Here we describe the 
clinico-pathological features of our case with a review 
of the few cases reported in literature.
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INTRODUCTION
Hepatocellular carcinoma (HCC) is one of the most 
frequent malignancies in the world; in particular, it is 
the fifth most common cancer in men and the seventh 
most common cancer in women, and it represents 
the third most frequent cause of death from cancer. 
Persistent infections by hepatitis B virus (HBV) and/or 
hepatitis C virus (HCV) are the main recognized risk 
factor for HCC. In addition, heavy alcohol drinking, 
smoking, overweight status, diabetes and familial/
genetic factors play an important role, especially in 
high-income countries[1]. Despite all of the recent 
advances in diagnostic and therapeutic approaches 
for the treatment of HCC, the prognosis is still poor, 
and long-term survival after disease onset is an 
exception[2]. Lymphoepithelioma-like carcinomas 
(LELCs) are a particular form of undifferentiated 
carcinoma characterized by a predominant lymphoid 
component that was originally described in the 
nasopharynx. Beyond the nasopharynx, these tumors 
are reported to occur in several organs, such as 
the salivary glands[3], lungs[4], stomach[5], colon[6] 
and thymus[7]; less frequently, they are reported in 
the uterine cervix[8], vagina[9], ovaries[10], bladder 
and urinary tract[11], trachea[12], lacrimal glands[13], 
breast[14], soft tissues[15] and skin[16]. Epstein-Barr virus 
(EBV) has been shown to be strongly connected to 
LELCs at several anatomic sites, such as the stomach, 
salivary glands, lung, and thymus[7]. Racial and/or 
geographic factors seem to influence the association of 
EBV with LELC in several of these organs. Specifically, 
the association of EBV with LELC of the salivary gland 
and lung is restricted to Asian patients, whereas 
the association of EBV with gastric and thymic 
LELCs seems to be independent of race[7]. However, 
regardless of EBV status, the morphologic features and 
prognosis seem to be the same, except for LELCs at 
uncommon sites for which the prognostic information 
is limited[17]. In the hepatobiliary tract, primary LELCs 
are rare. The World Health Organization (WHO) has 
only recently recognized LELCs as a variant of HCC 
(LEL-HCC). In 2000, Emile et al[18] reported a case 
of HCC with lymphoid stroma that was characterized 
by a good prognosis after liver transplant and by 
negativity for EBV infection. These authors were the 
first to suggest that HCC with these aspects should 
be considered as a distinct clinicopathological and 
prognostic entity. Before 2000, several case reports 
described the clinicopathological features of the 
marked inflammatory cell infiltration in HCC, but the 
term “LEL-HCC” was not used, and it is not completely 
clear whether the features of HCC described before 
2000 are distinguishable from those reported as 
features of LEL-HCC after that year[19]. To date, the 
majority of LELCs identified in the hepatobiliary tract 
are cholangiocarcinomas, whereas only ten cases of 
LEL-HCC have been described, in six reports, from 
2000 to 2013[2,18-22]. In 2014, Patel et al[17] reviewed all 
cases of HCC at their institution, starting from 1988, 
and identified 8 cases of LEL-HCC; in a 2015 study, 
Chan et al[23] have reported 20 cases of LEL-HCC 
from a 9-year retrospective cohort of 409 patients 
who underwent surgical resection for primary HCC. 
Considering also these retrospective studies, to the 
best of our knowledge, thirty-eight cases of LEL-HCC 
have been described from 2000 until now, with only 
one LEL-HCC case being positive for EBV[20]. Here, we 
describe a case of LEL-HCC in an 81-year-old woman, 
the eldest patient to have been described, and to 
further understand the disease’s characteristics, we 
review previous cases reported after the term “LEL-
HCC” first appeared in 2000.
CASE REPORT
An 81-year-old woman with a chronic hepatitis 
C infection was referred to the general surgery 
department of our hospital in October 2013 with 
a diagnosis of HCC. Her past medical history was 
significant for hypertension, venous insufficiency 
and osteoarthrosis. An ultrasound (US) evaluation 
conducted in July 2013 during a periodic medical 
Cacciato Insilla A et al . An uncommon variant of hepathocellular carcinoma
10469 September 28, 2015|Volume 21|Issue 36|WJG|www.wjgnet.com
investigation revealed the presence of a 60 mm, 
irregular pericholecystic node in the third hepatic 
segment, and the collateral liver parenchyma 
showed certain foci of steatofibrosis. The US exam 
was repeated after intravenous injection of 2.4 mL 
SonoVue, revealing a mosaic pattern in the lesion, 
with diffuse contrast enhancement, during the arterial 
phase and hypoenhancement during the portal and 
late phases. These findings suggested a malignant 
nature for the lesion. An abdominal contrast-enhanced 
computerized tomography (CT) scan confirmed the 
presence of a nodular lesion in the liver, with clear-
cut enhancement in the arterial phase and rapid 
wash-out in the portal venous and delayed phases 
(Figure 1). The CT scan also revealed the presence of 
a second 15 mm nodular lesion involving the wall of 
the gastric antrum, for which the patient underwent 
an endoscopic examination that yielded a negative 
result. A subsequent examination of a biopsy sample 
from the hepatic lesion was performed in August 2013 
confirmed the suspicion of HCC. A surgical operation 
was carried out on October 10th, 2013. A physical 
examination prior to the operation revealed mild, 
diffuse abdominal tenderness with normal auscultatory 
bowel sounds and peristaltic rushes. Pre-surgical 
laboratory tests revealed the following results: an 
alanine aminotransferase level of 23 IU/L (normal 
range 2-34 IU/L), an aspartate aminotransferase 
level of 29 IU/L (normal range 2-31 IU/L), a gamma-
glutamyl transferase level of 22 IU/L (normal range 
9-40 IU/L), an alkaline phosphatase level of 44 IU/L 
(normal range 35-105 IU/L) and a total bilirubin level 
of 0.75 mg/dL (normal range 0.50-1.20 mg/dL). 
The serum level of alpha-fetoprotein was 80.5 kU/L 
(normal range < 6.0 kU/L), of CEA was 1.1 microg/
L (normal range 0-5.0 microg/L), and of CA19-9 
was 13 kU/L (normal range 0-27 kU/L). Serological 
tests were positive for anti-HCV antibodies, HCV 
RNA and also for anti-HAV IgG but were negative 
for anti-HBV antibodies. The patient underwent a 
surgical operation with resection of the third hepatic 
segment and removal of the 15 mm nodule on the 
gastric wall, identified thanks to the CT scan. During 
the surgical operation, another 2 mm nodule on 
the gastric wall, close to the lesser curvature, was 
detected and removed. Macroscopically, the hepatic 
tumor was a 72 mm, yellowish, encapsulated solid 
mass 15 mm from the nearest resection margin. 
Microscopically, the neoplasm was composed of 
poorly differentiated, atypical, large epithelial cells 
characterized by an eosinophilic cytoplasm, large 
nuclei, and prominent nucleoli. The epithelial cells 
were surrounded by dense lymphoid stroma extending 
inside the tumor. The collateral liver parenchyma 
showed morphological aspects of HCV-related chronic 
hepatitis. Immunohistochemical analyses revealed 
that the neoplastic cells were positive for CK CAM5.2, 
CK8, CK18, and CEA (polyclonal, with a canalicular 
expression pattern) and had only focal positivity for 
hepar-1. The lymphocytes in the lymphoid stroma 
were predominantly positive for CD3, with the majority 
of them also positive for CD4 and fewer for CD8 (Figure 
2). The carcinoma cells were negative for EBV. As a 
consequence of these results, we classified this poorly 
differentiated HCC with heavy lymphoid infiltration 
as LEL-HCC. The two gastric nodules were ultimately 
identified as gastrointestinal stromal tumors (GISTs) 
that were positive for CD117 and CD34, and a specific 
mutation in exon 11 of the c-Kit gene was identified 
in both of the two nodules. PDGFRA mutations were 
absent. The patient has been alive and disease free 
during the 15 mo since the operation.
DISCUSSION
LELCs are undifferentiated carcinomas with prominent 
lymphoid stroma. LELCs in the liver have been 
reported, but most of these cases have instead been 
referred to as LEL-cholangiocarcinomas[19]. LEL-HCCs 
seem to have been first described in 2000 by Emile et 
al[18], who studied 162 HCCs in explanted livers, finding 
5 cases of HCC with abundant lymphoid stroma. 
Before 2000, there were several case reports in which 
the clinicopathological features of marked inflam-
matory cell infiltration in HCC were described, but the 
term “LEL-HCC” was not used. Since the five cases 
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Figure 1  computerized tomography scan. Left liver neoplasm (segments Ⅲ and Ⅳ), hypervascular (A) with rapid portal-phase wash-out (B).
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size was 4.3 cm (range, 1 cm[21] to 13 cm[17]). HBV and 
HCV serology showed variable patterns: fifteen cases 
were negative for both, two cases were positive for 
both and those that remained were positive only for 
one of the two (in particular, four were HCV positive, 
and eighteen was HBV positive). Fifteen patients had 
cirrhosis. Alpha-fetoprotein levels were reported in 
thirty-seven cases, and they were elevated in eighteen 
of them. All of the lesions were described as 
undifferentiated tumors with similar morphological 
aspects and abundant lymphocytic infiltration. 
Immunohistochemical studies were performed on 
nearly all of the lesions to better define the 
characteristics of the inflammatory infiltration. All of 
the prior reports showed a predominance of T cells 
over B cells, except in one case in which the cell 
dominancy was not documented[21]. The T-cell markers 
investigated varied among the reports. In the five 
cases reported by Emile et al, the mean CD3/CD20 
ratio was 11/1[18,19]. Si and colleagues investigated 
CD20 and CD3 in the infiltrating cells and described a 
mixed lymphocytic population with an excess of T 
cells[19,20]. In their work, Park and Nemolato also 
observed a prevalence of T cells, with a predominance 
of CD4-positive cells in the first report[20] and a 
predominance of CD8-positive cells in the second 
report[22]. In all eight cases reviewed by Patel et al[17], 
a predominance of T lymphocytes was observed, with 
an equal distribution of CD4- and CD8-positive cells. 
Finally, also Chan et al[23] reported a predominance of 
were reported in 2000 by Emile, only five additional 
cases of HCC with marked lymphoid stroma have been 
documented as LEL-HCC, in five different articles[2,19-22]. 
In 2014, Patel et al[17] reviewed all cases of HCC at 
their institution, starting from 1988, and identified 8 
cases of LEL-HCC. In a 2015 study, Chan et al[23] have 
reported 20 cases of LEL-HCC from a 9-year 
retrospective cohort of 409 patients who underwent 
surgical resection for primary HCC; considering also 
these retrospective studies, to the best of our 
knowledge, only thirty-eight cases of LEL-HCC have 
been described in the English-language medical 
literature from 2000 to date. The clinicopathological 
and prognostic features as well as the criteria for the 
diagnosis of LELCs at uncommon sites, such as the 
liver, are not clear. In this article, we describe a case of 
LEL-HCC in an 81-year-old woman, the eldest patient 
to have been reported, and to further understand the 
disease’s characteristics, we review previous cases 
reported after the term “LEL-HCC” first appeared in 
2000. In Tables 1 and 2, we have summarized the 
features of the ten cases reported since the proposal 
of Emile et al and, in addition, the data of the 
retrospective studies by Patel and Chan. Among all of 
the cases of LEL-HCCs reported, there were twenty-
three males and sixteen females, with a mean age of 
59.7 years (the youngest was 39 years old[21] and the 
eldest, 81, was described in the present case). Single 
tumors were reported in thirty-four cases, and multiple 
tumors were reported in five cases. The mean tumor 
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Figure 2  Neoplastic cells surrounded by a dense lymphoid infiltrate. A: hematoxylin/eosin stain x 200; B: CD3 immunostain x 200; C: CD4 immunostain x 200; D: 
CD8 immunostain x 200. 
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T lymphocytes with a mean CD8/CD4 ratio of 6.0/1. In 
our case, we observed a high predominance of T cells, 
many of which were CD4 positive, with only a few 
CD8-positive cells at the edge of the lesion. Many 
authors have suggested that HCC with lymphoid 
stroma has a favorable prognosis[17,19]. Human solid 
tumors are often infiltrated by lymphocytes, and the 
degree of the infiltration appears to be a favorable 
prognostic factor. As a mechanism of favorable 
prognosis, involvement of the antitumor effects of 
cellular immunity, mainly mediated by T lymphocytes, 
and of humoral immunity, mediated by B lymphocytes, 
have been considered[2]. Emile et al[18], for instance, 
suggested that HCCs with lymphoid stroma had a 
better prognosis than those without, possibly due to 
an antitumor effect related to the lymphocytic 
infiltration. However, Si et al[20] have described an 
aggressive case of LEL-HCC in a very young patient 
who died 5 mo after transplant surgery because of 
recurrence in the transplanted liver. Chen et al[21] also 
reported a case of LEL-HCC, in which the tumor was 
well encapsulated and did not have microvascular 
invasion, with a poor outcome[19]. Among all of the 
cases described after 2000, three patients died of HCC 
after surgery, whereas the other seven were still alive 
after 55.3 mo[19]. Among the eight cases described by 
Patel et al[17] in their retrospective study, three were 
still alive, without disease, after a mean period of 68 
mo; one was alive with recurrence 48 mo after 
surgery; one died because of the disease after 24 mo; 
and the last three died of causes not related to the 
disease. Finally, all the cases described by Chan et al 
were associated with a 2-year survival rate of 100% 
and a 5-year survival rate of 94.1%[23,24]. Although 
many authors have highlighted that LEL-HCCs have a 
better prognosis than conventional carcinomas with 
less marked lymphocytic infiltrate do[22,23], the few 
reports present in the English-language medical 
literature supply poor clinical information and show a 
variable course for the disease, suggesting that further 
accumulation of cases and studies is needed to 
determine the real biological behavior of LEL-HCC. An 
additional point of interest discussed in every report is 
the possible association between LEL-HCC and EBV. 
EBV is a lymphotropic virus that belongs to the 
Herpesviridae family and that infects over 90% of 
adults worldwide. This virus is closely associated with a 
variety of human neoplasms, such as Burkitt’s 
lymphoma, Hodgkin lymphoma, nasopharyngeal 
carcinoma and a subset of gastric carcinoma that is 
defined as EBV-associated gastric carcinoma[19,25]. EBV 
has been shown to be strongly connected to LELCs at 
10472 September 28, 2015|Volume 21|Issue 36|WJG|www.wjgnet.com
Table 2  Clinicopathological features of lymphoepithelioma-like hepatocellular carcinoma reported by Chan et al [23] in March 2015 
in their 9-year retrospective study
No. of cases Age (mean) Sex (M/F) Multifocal Tumor size 
(mean, cm)
HBV HCV EBV Cirrhosis AFP (> 20 mg/L) Outcome (5-yr survival)
20 57.5 13/7 - 3.8 17 - - 8 13 94.1%
HBV: Hepatitis B virus; HCV: Hepatitis C virus; EBV: Epstein-Barr virus; AFP: Alpha-fetoprotein; N: Normal; E: Elevated. 
Table 1  Clinicopathological features of lymphoepithelioma-like hepatocellular carcinoma reported in the literature until 2015
Case (ref.) Age 
(yr)
Sex/
Race
Multifocal Tumor 
size (cm)
HBV HCV EBV Cirrhosis AFP Preoperative 
therapy
Postoperative 
therapy
Outcome
1 (18) 50 M/W No 4 + + - + N None None Alive w/o recurrence (10 yr)
2 (18) 54 M/W Yes 2 - - - - N Chemo-emb None DOD (7.7 yr)
3 (18) 59 M/W Yes 5 + + - + N None Adj chemo Alive w/o recurrence (8 yr)
4 (18) 45 M/W No 2 - + - + N None Adj chemo Alive w/o recurrence (4.7 yr)
5 (18) 64 M/W Yes 4 - - - + N Chemo-emb Adj chemo Alive w/o recurrence (3 yr)
6 (20) 39 F/H No 1 - + + + - None None DOD (5 mo)
7 (21) 56 M/? No 3 - + - + N None Chemo for 
recurrence
DOD (21 mo)
8 (22) 47 F/? No    2.2 - - - - - None Not describe Alive w/o recurrence (15 mo)
9 (2) 57 M/? No    2.7 + - - + E None Not describe Alive w/o recurrence (50 mo)
10 (19) 79 M/A No 5 - - - - E None Chemo for 
recurrence
Alive with recurrence (20 mo)
11 (17) 74 F/W Yes    6.5 - - - - N None Not describe DOD 
12 (17) 65 M/W No    4.8 - - - - N None Not describe Died of unrelated cause
13 (17) 65 F/W No    1.3 - - - - E None Not describe Alive w/o recurrence
14 (17) 70 F/W No    2.7 - - - - E None Not describe Alive w/o recurrence
15 (17) 61 F/W Yes    9.5 - - - - N None Not describe Died of unrelated cause
16 (17) 78 M/W No   10.5 - - - - N None Not describe Alive with recurrence
17 (17) 78 F/W No   6 - - - - N None Not describe Alive w/o recurrence
18 (17) 57 F/W No 13 - - - - N Yes (unknown) Not describe Died of unrelated cause
19 (present 
case)
81 F/W No     7.2 - + - - E None None Alive w/o recurrence (15 mo)
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several anatomic sites, such as the stomach, salivary 
glands, lung, and thymus[7]. With regard to neoplasms 
in the hepatobiliary system, a strong relationship 
between EBV and LEL-cholangiocarcinomas has been 
demonstrated. In contrast, only one case of EBV-
positive LEL-HCC has been described in the literature, 
by Si et al in 2004; in particular, the patient was the 
youngest patient described, with the worst clinical 
course, multiple recurrences three mo after liver 
transplantation and death of the patient within several 
weeks. This is the only such case described in the 
literature, so we do not have enough information to 
posit a possible role for EBV infection in the poor 
outcome of the patient. It is unlikely that an asso-
ciation exists between LEL-HCC and EBV with respect 
to tumorigenesis. The biological implications of 
lymphoid infiltration in LEL-HCC are currently under 
debate, and the causes and consequences of this 
disease remain poorly understood[19]. In all of the 
cases reported after 2000, inflammatory infiltrates 
were predominantly composed of T cells, but certain 
discordances were present: certain authors reported 
the prevalence of CD4 over CD8 cells, several others 
reported a co-existence of CD4 and CD8 cells, and the 
prevalence of CD8 over CD4 cells has been reported in 
only one case. In conclusion, given all of these 
considerations, further studies are needed to better 
understand the genesis and behavior of LEL-HCCs. 
Finally, it should be highlighted that the synch-
ronous occurrence of HCC with GISTs, another very 
uncommon finding, has been rarely described in the 
literature[26].
COMMENTS
Case characteristics
A 81-year-old woman with a Lymphoepithelioma-like hepatocellular carcinoma 
(hCC) and synchronous gastrointestinal stromal tumor (GIST) of the stomach, 
a very unusual finding.
Clinical diagnosis
An ultrasound evaluation conducted during a periodic medical investigation in 
a patient with chronic hepatitis C infection revealed the presence of an irregular 
pericholecystic node.
Differential diagnosis
Classic hCC.
Laboratory diagnosis
Normal levels of transaminase, gamma-glutamyl transferase, alkaline 
phosphatase and bilirubin. high levels of α-fetoprotein and CEA.
Imaging diagnosis
An ultrasound evaluation revealed the presence of an irregular pericholecystic 
node. The ultrasound exam was repeated after intravenous injection of 2.4 
mL SonoVue and the result suggested a malignant nature for the lesion. An 
abdominal contrast-enhanced computerized tomography scan confirmed the 
presence of a nodular lesion in the liver and the suspect for malignant nature.
Pathological diagnosis
Microscopically, the neoplasm was composed of poorly differentiated, atypical, 
large epithelial cells characterized by an eosinophilic cytoplasm, large nuclei, 
and prominent nucleoli. The epithelial cells were surrounded by dense lymphoid 
stroma extending inside the tumor.
Treatment
Surgical operation with resection of the third hepatic segment.
experiences and lessons
The biological implications of lymphoid infiltration in lymphoepithelioma-like 
hCC (LEL-hCC) are currently under debate, and the causes and consequences 
of this disease remain poorly understood. This case report underline the fact 
that further studies are needed to better understand the genesis and behavior 
of LEL-hCCs. We also report the very unusual and uncommon association 
between two different kinds of neoplasia such as LEL-hCC and GIST. 
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This case report reported in detail all the cases of LEL-hCC described in the 
English literature within the time of the submission.
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